**Typical Accountabilities**:- Create and Build strong relationship with stakeholders involved in the diagnosis of Oncology patients (pathologist, surgeons, Histopathologists, oncologists, hematologists, Genetic and Molecular Biology Associations).- Identify opportunities to improve diagnosis based on a strong understanding and mapping of the current situation in the assigned territories and accounts.- Educate stakeholders (proactively and reactively) via a thorough understanding of the scientific information regarding Diagnosis, Molecular testing and Diagnostic techniques.- Implement high impact activities for each stakeholders based on the identified opportunities ensuring optimal return on investment- Meet objectives from the Business Operational Plans ensuring excellence in execution and strategic alignment- Support the Cross-functional team in monthly meeting by giving updated on actions, sharing insights and ensuring strategic alignment with team members from Promotion, Commercial, Medical and Access.- Support the Cross-functional team by providing insights on key KPIs aligned with the strategy to ensure the team is achieving their objectives and provide recommendations on corrective measures when necessary.- Being the point of contact between the account and testing labs in all matters related with diagnosis.- Follow the AstraZeneca Code of Conduct and ensure the highest level of compliance.- Regular meeting with Opinion Leaders and Influence groups to build partnership, share data, request support and provide technical support through publications, slide sets, round tables technical discussion.- Respond to requests for information about diagnostic / biomarkers testing unapproved in local markets, presenting objective information, well balanced, substantiated manner that is scientific in tone and content, free of promotional messages, truthful, and is not misleading.- Respond to requests by HCPs for information about technical details of biomarker (methodology, testing process, results interpretation).- Identify, map out and partner with national, regional/local Opinion Leaders and influence or advocacy groups for biomarkers testing inclusion / adoption.- Work with Pathology, Pulmonology, Genetic and Molecular biology association as partners in scientific activities that help advance biomarker understanding and are consistent with AZ strategy & objectives, such as:- Identify potential speakers and early adopters of biomarkers for patient´s management.- Provide recommendations for advisory board participants.**Support testing access by improving the testing environment**:- Contribute to testing platforms / techniques implementation in strategic markets in order to ensure access to biomarkers testing.- Facilitate continuous medical education events for HCPs, through activities that contribute to improve the diagnostic environment (access to testing and its inclusion the routine of patient's management).- Truly understands the market-specific diagnostic / testing environment, including the science, process, potential barriers and necessary commercial touch points to propose a treatment-linked diagnostic solution.- Has detailed knowledge of the interconnected Oncology ecosystem of patients, advocacy groups, KOLs, policy-makers, payers & HCPs and knows which decision makers influence the testing protocol- Participate in the educational material development about testing and ensure the main messages implementation in target audience (HCPs).- Contribute to external stakeholders' engagement about AZ testing program as value proposition that ensure accurate targeted therapies.- Define samples journey and support patient journey definition in each strategic account, establishing main patient leakage and proposing solutions to close the gaps.**Contribution to Brand and Diagnostic Strategy by supporting cross-functional team(s)**:- Provide AZ with an understanding of the local diagnostic environment and trends and competitor diagnostic initiatives in CAMCAR markets;- Develop educational activities providing scientific reference about relevance of biomarkers in the patient management in order to prepare the market in new therapeutic areas or indications.- Communicate HCPs findings, needs, barriers or opportunities with cross-functional team and partners (MSLs, KARs and LAMs).- Implement local diagnostic activities defined in account plans and speak up when identify a gap or is necessary to redirect local plans.**Facilitate Local Clinical Research (as appropriate)**:- Participate in development and conduction of local/regional studies with focus on biomarkers testing.- Upon request, assist with various aspects of local clinical trials, including scientific support, site selection and operational issues or feasibility assessments.- Lead local evidence generation about diagnostic (pre-analytical, analytical and post analytical), biomarker prevalence.- Ensure compliance
